Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design.
Journal of cardiovascular medicine (Hagerstown, Md.)（2023）
摘要
The study is registered in the EudraCT registry (number: 2017-004618-24) and in the ClinicalTrials.gov registry (identifier: NCT05728632).
更多查看译文
关键词
anthracycline chemotherapy, cancer therapy-related cardiovascular toxicity, cardio-oncology, nebivolol
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要